News
NIH-funded study finds immunotherapy slows progression of type 1 diabetes to clinical disease by 2 years or more
A treatment affecting the immune system effectively slowed the progression to clinical type 1 diabetes in high risk individuals, according to findings from National Institutes of Health-funded research.
